Dossier
QuidelOrtho
Coverage of QuidelOrtho in the Nexus archive.
- QuidelOrtho looks to sell testing unit as PE circles healthcare companies
QuidelOrtho plans to sell its testing unit amid private equity interest in healthcare companies. The company's shares have declined by 90% since its rapid antigen tests were the first approved for Covid-19.
- US Premarket Movers: Hims & Hers, PPG Industries, QuidelOrtho
S&P 500 Index futures rose 0.1% as an upbeat forecast from TSMC lifted technology shares, driving premarket gains for companies like Hims & Hers, PPG Industries, and QuidelOrtho.